A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 780 participants.
Also called NCT06458907
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 780 participants
- Sponsor
- P+F Products + Features USA Inc.
- Registry
-
NCT06458907
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06458907. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2028-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
- Acronym
- TRICAV-II
- Condition
- Tricuspid Valve Disease
- Condition
- Heart Valve Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Heart Failure
- Condition
- Tricuspid Valve Regurgitation
- Condition
- Tricuspid Valve Insufficiency
- Intervention (Device)
- TricValve System
- Intervention (Drug)
- Optimal medical therapy
- Lead sponsor
- P+F Products + Features USA Inc.
- Collaborator
- Meditrial USA Inc.
Record details
- Record id
cardio:ct-nct06458907- Content hash
63f0e332ff130330fab97be837344bb7558e4170851573e8822cda25af044a9b